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Abstract
Se is an essential micronutrient for human health, and fluctuations in Se levels and the potential cellular dysfunction associated with it may
increase the risk for disease. Although Se has been shown to influence several biological pathways important in health, little is known about
the effect of Se on the expression of microRNA (miRNA) molecules regulating these pathways. To explore the potential role of Se-sensitive
miRNA in regulating pathways linked with colon cancer, we profiled the expression of 800 miRNA in the CaCo-2 human adenocarcinoma cell
line in response to a low-Se (72 h at <40 nM) environment using nCounter direct quantification. These data were then examined using a range
of in silico databases to identify experimentally validated miRNA–mRNA interactions and the biological pathways involved. We identified ten
Se-sensitive miRNA (hsa-miR-93-5p, hsa-miR-106a-5p, hsa-miR-205-5p, hsa-miR-200c-3p, hsa-miR-99b-5p, hsa-miR-302d-3p, hsa-miR-373-3p,
hsa-miR-483-3p, hsa-miR-512-5p and hsa-miR-4454), which regulate 3588 mRNA in key pathways such as the cell cycle, the cellular response
to stress, and the canonical Wnt/β-catenin, p53 and ERK/MAPK signalling pathways. Our data show that the effects of low Se on biological
pathways may, in part, be due to these ten Se-sensitive miRNA. Dysregulation of the cell cycle and of the stress response pathways due to low
Se may influence key genes involved in carcinogenesis.
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Se is an essential micronutrient for human health(1,2). It is
incorporated as selenocysteine into approximately twenty-five
Se-containing enzymes (selenoproteins), which have been
proposed to have fundamental roles in oxidative defence pathways,
thyroid hormone production, inflammation and cardiovascular
health(3). Se status has also been linked to cancer risk on the basis
of cell, animal and epidemiological studies(4–19), but clinical studies
involving Se supplementation have been inconclusive(20). This
reflects our incomplete understanding of the mechanisms by
which selenoproteins function in complex interdependent cellular
pathways, how these are regulated, the effect of SNP in Se-sensitive
genes, which may alter how an individual responds to fluctuations
in Se status, and the differences in experimental design and
approaches. Inadequate Se and the potential cellular dysfunction
associated with it may increase the risk for disease(5,7). Severe
Se deficiency is rare but sub-optimal intake has been suggested to
be prevalent in many parts of the world, and the consequences
of inadequate Se status in existing diseases and/or the risk for
developing disease further is not well understood(5,7).
MicroRNA (miRNA) are small non-coding RNA, consisting
of nineteen to twenty-five nucleotides, which function as
regulators of gene expression by affecting translation of mRNA
into proteins(21–25). It has been shown that miRNA are critical for
the appropriate regulation of fundamental cellular pathways
and as such have been implicated in a range of processes that if
incorrectly regulated can lead to diseases such as cancer(2,5,7).
Furthermore, dietary factors are thought to influence miRNA
levels and potentially activate abnormal cellular pathways in
cancer development(26–31), and Se status has been shown to
affect miRNA levels in the CaCo-2 cell line(32). However, the
effect of dysregulated miRNA expression, due to a low-Se
environment, on key pathways in cancer development and
progression is unclear.
Colon cancer is the third most common cancer in men and
the second most common in women globally(33). The disease is
characterised by distinct mutations throughout life in key
biological cellular functions such as the Wnt/β-catenin, p53,
ERK/MAPK and the DNA mismatch repair pathways(34–39).
Several components of these canonical pathways have been
linked with abnormal miRNA activity(40,41) and Se status(42–51).
We hypothesised that there are miRNA whose expression is
dysregulated in a low-Se environment, and that this dysregulation
Abbreviations: miRNA, microRNA; qPCR, quantitative PCR.
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explains in part the effects of Se status on key biological
pathways. To investigate this hypothesis, we used cultured
CaCo-2 cells in a low-Se environment for 72h before
supplementation with or without 40nM Se (as sodium selenite).
The concentration of Se used (40nM) represents a concentration
comparable with plasma levels in people with optimal Se status. It
has been previously shown that 40 nM is adequate to maximise
expression of the Se-sensitive selenoprotein GPX1(18,52). The
absolute counts of 800 human miRNA were measured using
NanoString technology to characterise the miRNA profile in
response to a low-Se environment (<40nM) compared with
a 40-nM Se supplementation. These miRNA data were then
assessed in silico, only on the basis of experimentally validated
miRNA–mRNA interactions for their effects on biological
pathways based on the gene ontology and Reactome databases.
The intent of this study was to discover which miRNA were
sensitive to low Se so as to provide a robust data set for further
functional validation.
Methods
Cell culture and chemicals
Authenticated CaCo-2 human colon adenocarcinoma cells were
purchased from the American Type Culture Collection. All cell
culture reagents and chemicals were purchased from Life
Technologies unless otherwise stated. The cells were cultured
before the experiment in Dulbecco’s Modified Eagle’s Medium
(DMEM; Sigma-Aldrich), supplemented with 1% non-essential
amino acids, 1% penicillin–streptomycin solution and 10% fetal
bovine serum, and were maintained at 37°C with 5% CO2
in a humidified atmosphere. A low-Se medium was prepared
containing only DMEM, supplemented with 1% penicillin–
streptomycin solution, 5 µg/ml of insulin (Sigma-Aldrich) and
5 µg/ml of transferrin (Sigma-Aldrich).
The effect of Se supplementation in undifferentiated CaCo-2
cells was determined in three biologically independent assays.
For each experiment, 5× 105 CaCo-2 cells were seeded into three
wells of a six-well tissue-culture plate (Corning) and cultured at
37°C with 5% CO2 in DMEM-STD in a humidified atmosphere for
24h to facilitate attachment. The medium was then removed from
each well and the cells were washed twice with 1ml of PBS
(Life Technologies). The cells were then treated with 2·5ml per
well of fresh low-Se medium. The cells were then cultured at
37°C with 5% CO2 in a humidified atmosphere for 72h. The
low-Se medium was then removed from each well and the cells
were washed with 1ml of PBS. The cells were then treated with
2·5ml per well of fresh low-Se medium with or without 7 ng/ml
(40nM) of sodium selenite (Sigma-Aldrich) for 16h at 37°C with
5% CO2 in a humidified atmosphere.
Metabolic activity assay
The effect of supplementation of 40 nM Se on the metabolic
activity of CaCo-2 cells cultured in low Se for 72h was measured
using the water-soluble tetrazolium cytotoxicity assay (WST-1;
Clontech) as described previously(53). Metabolic activity was
assessed at T= 0h (low Se for 72h) and at T= 16h (with or
without 40nM Se, as described above) on three biological repli-
cates (with eight technical replicates each). Absorbance of the
formazan dye produced was measured at 450 and 650nm using a
FlexStation 3 Spectrophotometer (Molecular Devices). For all
measurements (including the blank), the background absorbance
(650nm) was subtracted from the detection wavelength (450nm)
and these corrected values were used for analysis.
Real-time PCR assay
The expression of the Se-sensitive genes, GPX1 and SEPW1,
was quantified using hydrolysis-probe-based real-time PCR.
After 16 h of low Se or treatment with 40 nM of sodium selenite,
RNA was extracted using the SV Total RNA Isolation System
(Promega) according to the manufacturer’s instructions, with
the quality and quantity of total RNA determined on the basis of
260:230 and 260:280 absorbance ratios using a NanoDrop 1000
Spectrophotometer (Thermo Fisher Scientific). A sample value
of 1·8–2·0 for each ratio was considered to be of sufficient
quality. The High-Capacity RNA-to-cDNA kit (Life Techno-
logies) was used to prepare 2 µg of complementary DNA
(cDNA) from each RNA sample according to the manufacturer’s
instructions, and the cDNA samples were stored at –20°C until
required.
For real-time PCR analysis, the PrimeTime (Integrated DNA
Technologies) assays were used. All PCR (no-template controls
and samples) were prepared as quadruplicate 10 µl reactions
comprising a 9·0-µl aliquot of master mix (5·0 µl of 2× Kapa
Probe Fast Mix (KK4703; Kapa Biosystems), 0·5 µl of 20× Inte-
grated DNA Technologies (IDT) gene assay, 3·5 µl of nuclease-
free water (Life Technologies) and 1 µl of cDNA (at a one in ten
dilution in nuclease-free water). The thermal profile used was
as follows: 95°C for 20 s followed by forty cycles of 95°C for
3 s and 60°C for 30 s. The experiment was completed using
a Rotor-Gene 6000 quantitative PCR instrument (Qiagen).
These data were normalised to the geometric mean of the β-2
microglobulin (B2M) and the ribosomal protein L19 (RPL19)
reference genes, with the application of the comparative
quantification method with efficiency correction, and expressed
as fold changes (stressed v. unstressed). The efficiencies for all
PCR ranged between 1·93 and 2·01, where 2·0 represents 100%
efficiency. qPCR data were ranked and analysed using the
Kruskal–Wallis ANOVA method in SigmaStat 12.3 (Systat Soft-
ware Inc.). Following ANOVA, significantly different means
were identified using Tukey’s post hoc test. All data with
P< 0·05 were considered to be statistically significant.
Profiling of microRNA expression changes
The NanoString nCounter technology(54) was used to determine
the absolute counts of 800 human miRNA (Human v2 miRNA
Expression Assay; NanoString Technologies) in 150 ng of RNA
from each sample, as described in the real-time qPCR method.
The NanoString profiling was completed according to the
manufacturer’s instructions and the raw NanoString profiling
data were normalised to the geometric mean of the top 100
expressing miRNA and the absolute number of counts for each
miRNA was calculated using nSolver version 2.5 analysis
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software (NanoString Technologies). All data were analysed for
statistical significance using Student’s t test in nSolver version
2.5 software. Data having P< 0·05 were considered to be
statistically significant.
In silico data analyses
To explore the effect(s) of Se-sensitive miRNA on biological
pathways, we focused solely on miRNA–mRNA interactions,
which were experimentally validated using the DIANA-TarBase
version 7.0(55). These data were then used to assess which
pathways they were involved with on the basis of gene onto-
logies (Gene Ontology database(56–59)) and reaction events
(Reactome database version 57(60,61)). These data were mapped
using Ingenuity® Pathway Analysis software (IPA®; Qiagen).
Results
Culturing CaCo-2 cells in low selenium affects cell
metabolism and the expression of selenium status markers
To assess the effect of low Se on CaCo-2 viability and to confirm
a low-Se environment, we measured metabolic activity (WST-1
assay) and the expression of GPX1 and SEPW1 genes(18,62)
(real-time qPCR). The mean metabolic activity of CaCo-2 cells in
a low-Se environment was measured to be 79 (SEM 6)% of that
of CaCo-2 in a 40-nM Se-supplemented environment. The qPCR
data show that expression of the GPX1 and SEPW1 genes was
significantly lower in a low-Se environment than in the
40-nM Se-supplemented one (–2·93-fold SEM 0·84, P= 0·010 and
–2·73-fold SEM 1·02, P= 0·013, respectively). As these genes
have previously been shown to be highly sensitive to Se supply,
these data show that the cells grown in the low-Se medium did
have a low-Se status(18); thus, other Se-sensitive genes may also
have responded appropriately to the amount of Se present.
Low selenium affects microRNA expression in CaCo-2 cells
Of the 800 miRNA probes in the NanoString Codeset, the expres-
sion of ten miRNAwas found to be affected by low Se (Table 1). On
the basis of experimentally verified miRNA–mRNA interactions from
the DIANA-TarBase version 7.0 database(55), these ten Se-sensitive
miRNA have 5364 interactions with 3588 distinct mRNA.
Selenium-sensitive microRNA expression affects genes
associated with cellular metabolism and signalling
To explore the potential biological implications of the findings
from Table 1, we utilised a range of open source databases for
our analyses. First, we used the Gene Ontology database(56) to
identify the biological processes that the mRNA targeted by
Se-sensitive miRNA are involved in, based on Protein ANnota-
tion THrough Evolutionary Relationship (PANTHER) over-
representation analysis(59) (Fig. 1).
These data show that mRNA influenced by Se-sensitive
miRNA are involved in key biological processes. While
exploring the effects of Se-sensitive miRNA on mRNA on the
basis of gene ontology pathways, the findings do not necessa-
rily translate into biological interactions at the protein or the
metabolite level. To clarify these effects, we further examined
our data using the Reactome database, which uses reactions
between entities (e.g. nucleic acids, proteins, complexes and
small molecules) as the central point, rather than just gene
interactions and associations.
Selenium-sensitive microRNA affect genes associated with
the cell cycle and the cellular response to stress
On the basis of Reactome database analyses of the mRNA tar-
geted by the ten Se-sensitive miRNA (Table 1), the cell cycle
and the cellular response to stress pathways are, as expected,
the most significant pathways affected as a consequence of the
dysregulation of Se-sensitive miRNA (Table 2).
The genes within the cell cycle and the cellular response to
stress pathways, which are experimentally validated targets of
the ten Se-sensitive miRNA, are listed in Table 3. These data
show that, of the ten Se-sensitive miRNA, mir-93-5p targets the
majority of mRNA in these pathways, and that several histone-
cluster genes (particularly the histone H4 cluster) are the largest
family of mRNA that are targeted.
Table 1. The ten microRNA (miRNA) whose expression is altered by a low-selenium environment in the CaCo-2 cell line*
(Mean expression levels (EL) with their standard errors)
Low Se v. adequate Se
Mature miRNA Accession ID Mean EL SEM P miRNA–mRNA
hsa-miR-93-5p MIMAT0000093 0·48 0·14 0·037 2071
hsa-miR-106a-5p MIMAT0000103 0·24 0·02 0·005 1196
hsa-miR-205-5p MIMAT0000266 0·68 0·15 0·024 368
hsa-miR-200c-3p MIMAT0000617 0·74 0·19 0·036 835
hsa-miR-99b-5p MIMAT0000689 0·50 0·14 0·029 183
hsa-miR-302d-3p MIMAT0000718 1·81 0·09 0·013 231
hsa-miR-373-3p MIMAT0000726 0·66 0·08 0·006 134
hsa-miR-483-3p MIMAT0002173 0·74 0·18 0·041 199
hsa-miR-512-5p MIMAT0002822 0·72 0·17 0·035 59
hsa-miR-4454 MIMAT0018976 0·41 0·14 0·039 88
miRNA–mRNA, the number of unique interactions for a given miRNA within the overall 5364 experimentally supported interactions.
* EL compared with adequate Se (40nM, EL=1·0), of three independent replicates and was generated using nSolver (version 2.5) software and the
DIANA-TarBase version 7.0 database(55).
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These data show that considering both gene-based
pathway mapping (e.g. gene ontologies) and reaction events
(e.g. Reactome data) provides a more comprehensive
analyses of the consequences of genes targeted by Se-sensitive
miRNA.
Selenium-sensitive microRNA dysregulation may affect
appropriate regulation of cancer pathways
To explore the effect of dysregulated Se-sensitive miRNA
(Table 1) on genes associated with cancer pathways,
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Fig. 1. A heat map showing the gene ontologies affected by expression of selenium-responsive microRNA (miRNA). The intensity of the colours represents the log
(P value) of the probability that the association of miRNA–mRNA in a particular pathway occurred by chance. The lower the log (P value) the less likely these
associations occur by chance (indicated in red).
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we mapped the mRNA targets of these miRNA onto the
Wnt/β-catenin, p53 and ERK/MAPK pathways using Ingenuity
Pathway Analysis (Fig. 2–4). These data show that several
genes, for example, AKT, ERK1/2, MDM2, PIK3, RAS and p53,
in key colon cancer-associated pathways are targeted by
Se-sensitive miRNA (Table 1), indicating that fluctuations in
Se status may affect signalling pathways linked to colon cancer
development and progression.
Discussion
In our study, we hypothesised that there are miRNA whose
expression is dysregulated in a low-Se environment (<40 nM),
and that this dysregulation explains in part the effects of Se
status on key biological pathways. We have shown that there
are ten miRNA, which have been experimentally validated in
the literature, to target mRNA involved in key metabolic and
Table 3. The selenium-sensitive microRNA (miRNA) whose expression is altered by a low-selenium environment and their mRNA targets in the Reactome
pathways (Table 2)
Reactome pathways Low-Se miRNA Associated mRNA in Reactome pathway
Cell cycle (R-HSA-1640170) miR-106a-5p (FC=− 4·17) CCNB1, CDKN1A, HERC2, MDM4, PSMD13, PSME3, PSMF1, UBC, WEE1, WHSC1, YWHAB,
ZNF385A
miR-200c-3p (FC=− 1·59) BRCA1, CCNE2, CDK2, CDKN1B, MCM8, MDM4, PSMB4, RNF168, WEE1, WHSC1, YWHAG
miR-205-5p (FC=− 1·66) CCNB1, CCNB2, CDC20, CDC23, CDK1, PSMB8, PSMD1, PSMD13, PSMD2, PSMD7, PSME2,
RNF168, RPA2, TP53, TP53BP1
miR-302d-3p (FC= 1·81) CCNB1, CDK2, PSMB2, RAD1, ZNF385A
miR-373-3p (FC=− 1·57) MRE11A
miR-4454 (FC=− 3·03) YWHAB
miR-483-3p (FC=− 1·63) ANAPC11, MDM4, UBE2C
miR-93-5p (FC=− 2·43) ANAPC11, ANAPC5, BRE, CCNB1, CDC16, CDC6, CDKN1A, CDKN1B, FAM175A, H2AFX,
HIST1H2BD, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4H, HIST1H4I,
HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, HUS1, MAD2L1, MCM3,
MCM5, MDM2, MDM4, MRE11A, PIAS4, PKMYT1, PSMA4, PSMA7, PSMB4, PSMC1, PSMD11,
PSMD4, RBBP8, RFC3, RPA2, RPS27A, TP53, UBC, UBE2E1, WEE1, WHSC1, YWHAB,
YWHAQ, YWHAZ, ZNF385A
miR-99b-5p (FC=− 2·32) CHEK1, HIST1H2BK, MCM3, MCM4
Cellular responses to stress
(R-HSA-2262752)
miR-106a-5p (FC=− 4·17) AGO1, ARNT, ASF1A, ATG16L1, BAG5, CDKN1A, CDKN2C, CEBPB, CHMP3, CXCL8, E2F1,
EGLN1, EGLN3, EPAS1, ERO1A, ETS1, HIST1H3B, HMGA1, HMGA2, IL1A, LAMTOR1, MAPK1,
MAPK7, MAPK8, MAPKAPK3, MINK1, MTMR3, NUP205, NUP58, PHC2, PHC3, PIK3C3, PRDX3,
PRKAB2, RANBP2, RB1, RBBP7, RPS6KA2, RPS6KA3, RRAGD, SEH1L, SIRT1, SOD2, STAT3,
TNRC6A, TNRC6B, TXN, UBC, UBE2D3, ULK1, VEGFA
miR-200c-3p (FC=− 1·59) ATG12, BAG5, BMI1, CBX4, CCNE2, CDK2, CDKN1B, CEBPB, CHMP2B, E2F3, EP300, ETS1,
H2AFV, HSPA13, HSPA8, JUN, LMNB1, NUP160, NUP58, PHC3, RANBP2, RNF2, RPS6KA3,
SIRT1, SUZ12, TERF2, TSC1, VEGFA
miR-205-5p (FC=− 1·66) CDC23, CHMP2A, DNAJC7, E2F1, EED, GABARAPL1, HSPA8, HSPA9, NFKB1, NUP37, RBX1,
RPA2, RPS19BP1, RRAGA, SEH1L, TERF2IP, TP53, UBE2D3, VEGFA, VHL
miR-302d-3p (FC= 1·81) AGO3, BECN1, CDK2, MINK1, NUP88, RANBP2, SUZ12, TNRC6B, VEGFA
miR-373-3p (FC=− 1·57) CXCL8, HIF1A, HIF1AN, HSPA14, LMNB1, MRE11A, NUP153, NUP58, PHC2, PHC3, PRKAA1,
RELA, TNRC6A, VEGFA
miR-4454 (FC=− 3·03) CCAR2, HSPA1A, LAMTOR1, POT1, PRKAA1
miR-483-3p (FC=− 1·63) ANAPC11, EGLN2, EZH2, GSK3B, HMGA1, MAP1LC3B, MAPKAPK2, PHC3, PRKAA1, UBE2C,
WDR45B
miR-512-5p (FC=− 1·63) DNAJB1
miR-93-5p (FC=− 2·43) ACD, AGO1, AGO3, AGO4, AMBRA1, ANAPC11, ANAPC5, ASF1A, ATG16L1, ATG3, BAG2, CBX2,
CBX6, CBX8, CDC16, CDK4, CDKN1A, CDKN1B, CDKN2C, CHMP3, CITED2, CXCL8, E2F1,
EEF1A1, EGLN3, EP400, ERO1A, EZH2, GSK3B, H1F0, H2AFV, H2AFX, HIF1A, HIST1H2BD,
HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3I, HIST1H3J, HIST1H4A,
HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K,
HIST1H4L, HIST2H3A, HIST2H3C, HIST2H3D, HIST2H4A, HIST2H4B, HIST4H4, HMGA2,
HSBP1, HSP90AA1, HSPA4L, HSPA8, JUN, LAMTOR1, LAMTOR5, LMNB1, MAP3K5, MAPK1,
MAPK7, MAPK8, MAPK9, MDM2, MINK1, MRE11A, MTMR3, NUP107, NUP153, NUP188,
NUP205, NUP58, NUP62, NUPL2, PHC2, PHC3, PIK3C3, PRDX3, PRDX6, PRKAA2, PRKAB2,
PTGES3, RAE1, RANBP2, RB1, RBBP7, RNF2, RPA2, RPS27A, RPS6KA3, RRAGD, SOD2, SP1,
STAT3, SUZ12, TNRC6A, TNRC6B, TNRC6C, TP53, TPR, TSC1, TXN, UBC, UBE2D3, UBE2E1,
UBN1, ULK1, VCP, VEGFA, VHL, WIPI2
miR-99b-5p (FC=− 2·32) CBX6, CEBPB, ERF, H2AFZ, HIST1H1C, HIST1H2BK, MTOR, NUP43, SP1, TNRC6B, UBE2D2,
VEGFA
FC, fold change.
Table 2. A summary of the significant high-level reactome pathways containing genes whose expression is influenced
by the selenium-sensitive microRNA shown in Table 1*
Pathway ID Pathway name Entities† P Reactions‡
R-HSA-1640170 Cell cycle 237 0·018 91·49
R-HSA-2262752 Cellular responses to stress 177 0·024 84·39
* Data were derived from the Reactome database(60).
† The number of mapped entities, in this case genes that match the pathway.
‡ The percentage of reactions in a specified pathway with at least one mapped entity in the data set.
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signalling pathways (Table 3) and that canonical signalling
pathways in colon cancer are sensitive to Se (Fig. 2–4). To our
knowledge, these data are the first reported on Se-sensitive
miRNA on the basis of direct miRNA counts rather than on the
basis of relative quantification-based technologies such as
microarray and real-time qPCR. Furthermore, we explored the
pathways/processes that these miRNA targeted, considering
only their experimentally validated mRNA targets, on the basis
of gene ontologies and Reactome data. Importantly, our data
show that the effects of low Se on biological pathways may, in
part, be due to the dysregulation of the ten Se-sensitive miRNA
identified.
A previous study on the effects of Se status on miRNA used
microarray and real-time qPCR methods(32) and found that
thirty-four miRNA and fifty mRNA were dysregulated in low-Se
conditions in vitro. In contrast to our data, none of the
Se-sensitive miRNA reported in Table 1 was found to be affected
in that study. However, twenty-eight of these previously observed
miRNA were found in our data set, and despite not being
differently expressed in our data, the magnitude of the response
in expression was consistent. Interestingly, seven of the mRNA
(ATP1B3, CACYBP, CMIP, DCUN1D4, GPX4, MT1F and SEPHS2)
that showed altered expression are also targets of Se-sensitive
miRNA in our data set, despite little overlap in miRNA data(32).
Discrepancies between the two studies might be explained by the
use of different detection technologies (microarray v. NanoString)
and the updated Genome Reference Consortium Human build 38
used in this study.
The data from bioinformatic analysis (Table 3) show that key
genes in the cell cycle and the cellular response to stress are
regulated by the Se-sensitive miRNA identified in this study.
With respect to the cell cycle, genes regulating cell cycle pro-
gression, for example, cyclins (B1, B2, E2), cyclin-dependent
kinases (1 and 2) and cyclin-dependent kinase inhibitors (1A),
checkpoints (E2F1 and RB), and DNA licencing for replication
(MCM2 and MCM5) are influenced by Se-sensitive miRNA.
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Previous studies(12,15,16) have reported that Se status influences
the expression of these genes in disease, and the appropriate
regulation of the cell cycle by both mRNA and miRNA is
essential for preventing carcinogenic transformation. The
bioinformatic analysis also found that Se-sensitive miRNA
regulate the expression of genes involved in the cellular
response to stress, for example, antioxidant enzymes (SOD2),
mitogen-activated signalling cascades (MAPK1, MAPK7 and
MAPK8) and in the heat-shock stress responses (HSPA8,
HSPA9 and HSPA13). Se status is known to influence several
stress responses, such as those caused by oxidative and
unfolded protein stress(63–65), and our data suggest that
Se-sensitive miRNA may be influential in Se-mediated stress
responses.
We have also found that in CaCo-2 cells, inadequate Se
supply alters the expression profile of miRNA that regulate the
expression of key genes in the canonical Wnt/β-catenin, p53
and ERK/MAPK pathways (Fig. 2–4). Previous studies have
shown a link between Se status and the expression of genes in
these pathways(12–16,42,44–48); however, they did not assess the
effect of altered miRNA expression in response to Se status on
the genes that were Se sensitive in these pathways. Our data
suggest that fluctuations in Se status due to diet or ill health(5,7),
which result in dysregulated miRNA expression, may affect
the appropriate functioning of these pathways, influencing
pathogenesis in the colon.
Inadequate Se levels and the potential cellular dysfunction
associated with them may increase the risk for disease. Se supply
can be affected by compromised intestinal function – for example,
by inflammatory bowel disease(66), or by altered activity of key
genes due to SNP(5) – such that the consequences of fluctuating Se
status, exacerbated by inappropriate Se-sensitive miRNA-mediated
regulation, may have an important role in how intestinal diseases
such as cancer develop and progress.
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Although our study has identified that ten miRNA are sensitive
to Se status and that these miRNA target mRNA involved in the
cell cycle, cell stress response and in key cancer-associated
pathways, these findings require further validation. Our data are
based on experimental profiling of miRNA abundance and
in silico mRNA target analysis (based on experimentally
validated miRNA–mRNA interactions, but not necessarily in the
cell line used for this study). To robustly demonstrate that these Se
miRNA directly influence the mRNA and biological pathways
identified in this study, further functional validation, such as
protein abundance/activity analysis, is required. However,
our data provide a foundation on which to further study
the influence of Se status on miRNA-mediated regulation of
biological pathways.
Conclusions
Using a novel direct quantification method, we have identified ten
miRNA that are Se sensitive, which have been experimentally
validated in the literature to target mRNA involved in key meta-
bolic, signalling and canonical colon cancer pathways. Impor-
tantly, our data represent important preliminary knowledge of
how Se status affects miRNA expression and how these changes
may affect biological pathways. First, the data show that the
effects of low Se on biological pathways may, in part, be due to
the dysregulation of the ten Se-sensitive miRNA identified. Sec-
ond, the data identify the cell cycle and the stress response
pathways as being potentially affected by Se status through
miRNA expression. These findings contribute to an understanding
of how the regulation of miRNA by Se supply could potentially
influence the cells’ response to further challenges that may
ultimately lead to disease.
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